FDA NDC Directory · JSON-LD · Markdown

Herceptin Hylecta

NDC 50242-077 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameTrastuzumab and hyaluronidase-oysk
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761106
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsHYALURONIDASE (HUMAN RECOMBINANT) (10000 U/5mL)
TRASTUZUMAB (600 mg/5mL)
Marketing started20190228
Package count1

External sources

Source: openFDA. Public-domain (CC0).